SELLAS Life Sciences Group, Inc.SLSNASDAQ
Loading
Operating Expenses Over TimeContracting
Percentile Rank36
3Y CAGR-12.9%
5Y CAGR+8.4%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
-12.9%/yr
vs +7.9%/yr prior
5Y CAGR
+8.4%/yr
Recent deceleration
Acceleration
-20.9pp
Decelerating
Percentile
P36
Within normal range
vs 5Y Ago
1.5x
Solid growth
Streak
3 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $28.27M | -10.3% |
| 2024 | $31.51M | -16.8% |
| 2023 | $37.87M | -11.6% |
| 2022 | $42.85M | +31.1% |
| 2021 | $32.69M | +73.1% |
| 2020 | $18.88M | -5.8% |
| 2019 | $20.04M | -36.6% |
| 2018 | $31.59M | +49.3% |
| 2017 | $21.16M | -33.6% |
| 2016 | $31.87M | - |